Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Cardiovascular4053 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A43093 | 32587620 | Stem Cells Int | Human Adipose Derived Cells in Two- and Three-Dimensional Cultures: Functional Validation of an In Vitro Fat Construct. | 2020 | Details |
| A43105 | 32558697 | Eur J Gastroenterol Hepatol | COVID-19 and the liver: overview. | 2021 | Details |
| A43108 | 32549999 | Clin Hypertens | Uric acid and cardiometabolic diseases. | 2020 | Details |
| A43131 | 32482717 | J Lipid Res | Lecithin:cholesterol acyltransferase: symposium on 50 years of biomedical research from its discovery to latest findings. | 2020 | Details |
| A43145 | 32431189 | J Am Heart Assoc | Fibroblast Growth Factor 21 is Related to Atherosclerosis Independent of Nonalcoholic Fatty Liver Disease and Predicts Atherosclerotic Cardiovascular Events. | 2020 | Details |
| A43160 | 32403898 | Clin Exp Pediatr | Early menarche and its consequence in Korean female: reducing fructose intake could be one solution. | 2020 | Details |
| A43171 | 32378399 | J Obes Metab Syndr | Current Long-Term Pharmacotherapies for the Management of Obesity. | 2020 | Details |
| A43173 | 32374328 | Biomater Sci | A versatile ultrafine and super-absorptive H+-modified montmorillonite: application for metabolic syndrome intervention and gastric mucosal protection. | 2020 | Details |
| A43175 | 32368680 | Arch Med Sci Atheroscler Dis | Non-alcoholic fatty liver disease in patients with inflammatory bowel disease might boost cardiovascular disease burden. | 2019 | Details |
| A43190 | 32338785 | Aliment Pharmacol Ther | Editorial: re-thinking cardiovascular risk factors in NAFLD with advanced fibrosis? | 2020 | Details |
| A43191 | 32338780 | Aliment Pharmacol Ther | Editorial: re-thinking cardiovascular risk factors in NAFLD with advanced fibrosis? Authors' reply. | 2020 | Details |
| A43192 | 32338040 | Antioxid Redox Signal | Glycomacropeptide: A Bioactive Milk Derivative to Alleviate Metabolic Syndrome Outcomes. | 2020 | Details |
| A43194 | 32335802 | Front Med | Biological properties and clinical applications of berberine. | 2020 | Details |
| A43230 | 32229664 | J Basic Clin Physiol Pharmacol | Altered composition of high-lipid diet may generate reactive oxygen species by disturbing the balance of antioxidant and free radicals. | 2020 | Details |
| A43255 | 32143834 | Rev Clin Esp (Barc) | Clinical ultrasonography in cardiovascular risk. | 2020 | Details |
| A43301 | 32026275 | Dig Dis Sci | The Emerging Epidemic of Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: True, True, and Related? | 2020 | Details |
| A43304 | 32020441 | World J Pediatr | Childhood obesity, cardiovascular and liver health: a growing epidemic with age. | 2020 | Details |
| A43306 | 32012311 | Hepatology | Is Nonalcoholic Fatty Liver Disease Not a Risk Factor for Cardiovascular Disease: Not Yet Time for a Change of Heart. | 2020 | Details |
| A43319 | 31984784 | Am J Physiol Gastrointest Liver Physiol | Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy. | 2020 | Details |
| A43335 | 31979568 | J Assoc Physicians India | Assessment of Risk Factors for Cardiovascular Morbidity in Type 2 DM with and Without Non Alcoholic Fatty Liver Disease. | 2020 | Details |
| A43346 | 31933631 | Gastroenterol Res Pract | Liver Stiffness, Not Fat Liver Content, Predicts the Length of QTc Interval in Patients with Chronic Liver Disease. | 2019 | Details |
| A43352 | 31928362 | Eur J Prev Cardiol | The 'heart' of preventive cardiology: Lifestyle medicine for the treatment of cardiometabolic diseases. | 2020 | Details |
| A43360 | 31909364 | J Obes Metab Syndr | Effect of Diet on the Gut Microbiota Associated with Obesity. | 2019 | Details |
| A43361 | 31905423 | J Food Biochem | Dietary solutions to dyslipidemia: Milk protein-polysaccharide conjugates as liver biochemical enhancers. | 2020 | Details |
| A43388 | 31852301 | Eur J Prev Cardiol | Non-alcoholic fatty liver disease and cardiovascular disease: A still debated liaison. | 2019 | Details |
| A43401 | 31823334 | Probiotics Antimicrob Proteins | Therapeutic and Nutritional Effects of Synbiotic Yogurts in Children and Adults: a Clinical Review. | 2020 | Details |
| A43403 | 31820180 | Dig Dis Sci | Cardiovascular Risk in NAFLD: An Intimate Relationship? | 2020 | Details |
| A43408 | 31809300 | Am J Gastroenterol | Women With Nonalcoholic Fatty Liver Disease Lose Protection Against Cardiovascular Disease? | 2020 | Details |
| A43410 | 31801050 | Eur J Prev Cardiol | Non-alcoholic fatty liver disease, a new and growing risk indicator for cardiovascular disease. | 2019 | Details |
| A43419 | 31764586 | J Hypertens | Cardiovascular, renal and liver protection with novel antidiabetic agents beyond blood glucose lowering in type 2 diabetes: consensus article from the European Society of Hypertension Working Group on Obesity, Diabetes and the High-risk Patient. | 2020 | Details |
| A43425 | 31754898 | Curr Diab Rep | Hyperglycemia During Pregnancy and Long-Term Offspring Outcomes. | 2019 | Details |
| A43431 | 31732172 | J Neurol Sci | Response to letter to the editor by Kawada on "Association between nonalcoholic fatty liver disease with advanced fibrosis and stroke". | 2019 | Details |
| A43433 | 31727327 | J Neurol Sci | Nonalcoholic fatty liver disease with advanced fibrosis, stroke and cardiovascular disease. | 2019 | Details |
| A43446 | 31694146 | Nutrients | Relevance of Leptin and Other Adipokines in Obesity-Associated Cardiovascular Risk. | 2019 | Details |
| A43461 | 31657474 | Aliment Pharmacol Ther | Letter: role of mean platelet volume levels in the prediction of major acute cardiovascular events in patients with non-alcoholic fatty liver disease-authors' reply. | 2019 | Details |
| A43462 | 31657472 | Aliment Pharmacol Ther | Letter: role of mean platelet volume levels in the prediction of major acute cardiovascular events in patients with non-alcoholic fatty liver disease. | 2019 | Details |
| A43468 | 31649547 | Front Pharmacol | Mitophagy in Hepatic Insulin Resistance: Therapeutic Potential and Concerns. | 2019 | Details |
| A43476 | 31611648 | Nat Rev Endocrinol | The clinical potential of circulating microRNAs in obesity. | 2019 | Details |
| A43483 | 31597437 | Angiology | Reply to the Letter to the Editor Entitled: "The Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases". | 2019 | Details |
| A43486 | 31592705 | Metab Syndr Relat Disord | Triglycerides as a Metabolic Target in Afrocaribbean Infertile Women with Polycystic Ovary Syndrome. | 2019 | Details |
| A43581 | 31356096 | Arch Iran Med | Comparing Anthropometric Indicators of Visceral and General Adiposity as Determinants of Overall and Cardiovascular Mortality. | 2019 | Details |
| A43589 | 31341440 | Integr Med (Encinitas) | Barrie Tan, PhD: Using Tocotrienols to Address Lifestyle and Metabolic Disease. | 2019 | Details |
| A43595 | 31323122 | Hepatology | Risks of Light and Moderate Alcohol Use in Fatty Liver Disease: Follow-Up of Population Cohorts. | 2019 | Details |
| A43596 | 31319680 | Angiology | The Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases. | 2019 | Details |
| A43603 | 31310401 | Liver Int | Author response to Letter to the Editor: "Statins and non-alcoholic fatty liver disease". | 2019 | Details |
| A43611 | 31294797 | J Burn Care Res | The Influence of Obesity on Treatment and Outcome of Severely Burned Patients. | 2019 | Details |
| A43613 | 31290314 | J Proteome Res | Lipidomics Reveals Similar Changes in Serum Phospholipid Signatures of Overweight and Obese Pediatric Subjects. | 2019 | Details |
| A43643 | 31227258 | J Hepatol | Hepatic fat: Pathogenic trigger or passenger? | 2019 | Details |
| A43646 | 31225638 | Br J Dermatol | Management of psoriasis as a systemic disease: what is the evidence? | 2019 | Details |
| A43650 | 31200402 | Klin Lab Diagn | [Insulin resistance is an alimentary deficiency of energy substrates (glucose) in the biological reaction of exotrophy and aphysiology compensation by fatty acids via the biological reaction of endothrophy.] | 2019 | Details |
| A43670 | 31142103 | Clin Mol Hepatol | Serum leptin in non-alcoholic fatty liver disease: Ambiguous clinical implications concerning cardiovascular disease. | 2019 | Details |
| A43683 | 31106419 | J Cell Physiol | Impact of different ectopic fat depots on cardiovascular and metabolic diseases. | 2019 | Details |
| A43702 | 31081583 | Liver Int | Statins and non-alcoholic fatty liver disease. | 2019 | Details |
| A43717 | 31040498 | Mo Med | Pediatric Fatty Liver Disease. | 2019 | Details |
| A43742 | 30988909 | Clin Liver Dis (Hoboken) | The Association Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease Outcomes. | 2018 | Details |
| A43745 | 30985734 | Transplantation | The Impact of Preexisting and Post-transplant Diabetes Mellitus on Outcomes Following Liver Transplantation. | 2019 | Details |
| A43757 | 30949667 | J Nutr | Consumption of Alcoholic and Sugar-Sweetened Beverages is Associated with Increased Liver Fat Content in Middle-Aged Men and Women. | 2019 | Details |
| A43761 | 30946528 | FEBS J | Role of elastin peptides and elastin receptor complex in metabolic and cardiovascular diseases. | 2019 | Details |
| A43762 | 30945509 | Zhen Ci Yan Jiu | [Progress of researches on mechanisms of acupuncture therapy for insulin resistance]. | 2019 | Details |
| A43767 | 30920047 | Aliment Pharmacol Ther | Editorial: importance of an elevated mean platelet volume for prediction of major adverse cardiovascular events in non-alcoholic fatty liver disease. | 2019 | Details |
| A43768 | 30920045 | Aliment Pharmacol Ther | Editorial: importance of an elevated mean platelet volume for prediction of major adverse cardiovascular events in non-alcoholic fatty liver disease - authors' reply. | 2019 | Details |
| A43781 | 30894877 | Evid Based Complement Alternat Med | BuShenKangShuai Tablet Alleviates Hepatic Steatosis via Improving Liver Adiponectin Resistance in ApoE-/- Mice. | 2019 | Details |
| A43815 | 30816074 | Curr Vasc Pharmacol | Menopause and its Cardiometabolic Consequences: Current Perspectives. | 2019 | Details |
| A43819 | 30791787 | Expert Rev Gastroenterol Hepatol | Non-alcoholic fatty liver disease and cardiovascular risk: an update. | 2018 | Details |
| A43822 | 30789748 | Am J Physiol Gastrointest Liver Physiol | Inhibition of soluble epoxide hydrolase ameliorates hyperhomocysteinemia-induced hepatic steatosis by enhancing β-oxidation of fatty acid in mice. | 2019 | Details |
| A43838 | 30741841 | J Clin Gastroenterol | Thirty Years of Lactobacillus rhamnosus GG: A Review. | 2019 | Details |
| A43845 | 30706731 | Diab Vasc Dis Res | Pioglitazone: The forgotten, cost-effective cardioprotective drug for type 2 diabetes. | 2019 | Details |
| A43860 | 30670052 | Lipids Health Dis | Effects of exercise training on Fetuin-a in obese, type 2 diabetes and cardiovascular disease in adults and elderly: a systematic review and Meta-analysis. | 2019 | Details |
| A43870 | 30642561 | Am J Med | Non-Alcoholic Fatty Liver Disease and Disease Mongering. | 2019 | Details |
| A43876 | 30615269 | Liver Int | Reply to Mantovani: "Causality between non-alcoholic fatty liver disease and risk of cardiovascular disease and type 2 diabetes". | 2019 | Details |
| A43883 | 30581509 | Prz Gastroenterol | Empagliflozin promises to bridge the gap between non-alcoholic fatty liver disease, type 2 diabetes, and cardiovascular disease. | 2018 | Details |
| A43893 | 30548562 | Liver Int | Causality between non-alcoholic fatty liver disease and risk of cardiovascular disease and type 2 diabetes. | 2019 | Details |
| A43895 | 30522511 | Lipids Health Dis | Cordycepin reduces weight through regulating gut microbiota in high-fat diet-induced obese rats. | 2018 | Details |
| A43924 | 30444584 | J Dig Dis | Guidelines of prevention and treatment of nonalcoholic fatty liver disease (2018, China). | 2018 | Details |
| A43938 | 30408104 | PLoS One | Effects of fructose-containing sweeteners on fructose intestinal, hepatic, and oral bioavailability in dual-catheterized rats. | 2018 | Details |
| A43961 | 30316414 | Fertil Steril | Beyond fertility: polycystic ovary syndrome and long-term health. | 2018 | Details |
| A43974 | 30265151 | Am J Physiol Heart Circ Physiol | Western diet triggers Toll-like receptor 4 signaling-induced endothelial dysfunction in female Wistar rats. | 2018 | Details |
| A43989 | 30215326 | Cardiovasc Hematol Agents Med Chem | Cardiovascular and Hematological Medicine in 2018 - Advances and Insights. | 2019 | Details |
| A43992 | 30203590 | Helicobacter | Helicobacter pylori and extragastric diseases. | 2018 | Details |
| A44025 | 30119271 | Biomed Pharmacother | Diabetes and hepatocellular carcinoma: A pathophysiological link and pharmacological management. | 2018 | Details |
| A44029 | 30099111 | Clin Gastroenterol Hepatol | Sex-Based Differences in the Association Between Nonalcoholic Fatty Liver Disease and Mortality. | 2018 | Details |
| A44053 | 30027138 | Hepatol Commun | Patatin-like phospholipase domain containing 3 variants differentially impact metabolic traits in individuals at high risk for cardiovascular events. | 2018 | Details |
| A44064 | 29995306 | Eur J Clin Invest | Adipokine dysregulation and adipose tissue inflammation in human obesity. | 2018 | Details |
| A44065 | 29993258 | Crit Rev Food Sci Nutr | The target cells of anthocyanins in metabolic syndrome. | 2018 | Details |
| A44092 | 29778300 | J Hepatol | Imaging endpoints for non-alcoholic steatohepatitis (NASH) therapeutic trials: A growing role for multiparametric MRI? | 2018 | Details |
| A44094 | 29768950 | Expert Rev Gastroenterol Hepatol | Statins in liver disease: not only prevention of cardiovascular events. | 2018 | Details |
| A44110 | 29731078 | Transplant Proc | Diabetes With or Without Hypertension Does Not Affect Graft Survival and All-cause Mortality After Liver Transplant: A Propensity Score Matching Analysis. | 2018 | Details |
| A44116 | 29702499 | Curr Opin Cardiol | New antihyperglycaemic agents and cardiovascular disease: let's be optimistic. | 2018 | Details |
| A44126 | 29653253 | Biochim Biophys Acta Mol Cell Biol Lipids | Cholesterol and bile acid-mediated regulation of autophagy in fatty liver diseases and atherosclerosis. | 2018 | Details |
| A44145 | 29598814 | Curr Vasc Pharmacol | Editorial: Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis: An Epidemic that will Boost the Incidence of Cardiovascular Morbidity and Mortality. | 2018 | Details |
| A44152 | 29570245 | Obesity (Silver Spring) | Nonnutritive Sweeteners in Weight Management and Chronic Disease: A Review. | 2018 | Details |
| A44158 | 29549356 | Am J Gastroenterol | The management of incidental fatty liver found on imaging. What do we need to do? | 2018 | Details |
| A44170 | 29523556 | Circ Cardiovasc Imaging | Prevalent Cardiovascular Disease Events and T1 Mapping Defined Hepatic Fibrosis. | 2018 | Details |
| A44171 | 29522277 | Obesity (Silver Spring) | High Body Adiposity Drives Glucose Intolerance and Increases Cardiovascular Risk in Normoglycemic Subjects. | 2018 | Details |
| A44184 | 29474973 | Clin Gastroenterol Hepatol | Nonalcoholic Fatty Liver Disease and Mortality. | 2018 | Details |
| A44194 | 29465311 | FASEB J | p32 regulates ER stress and lipid homeostasis by down-regulating GCS1 expression. | 2018 | Details |
| A44260 | 29210655 | Curr Vasc Pharmacol | Editorial: Recent News on Statins for the Treatment of Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis. | 2018 | Details |
| A44278 | 29168826 | Nature | Drug development: Sprint finish. | 2017 | Details |
| A44301 | 29101348 | Sci Rep | Plasma amino acid profile associated with fatty liver disease and co-occurrence of metabolic risk factors. | 2017 | Details |
| A44342 | 28912810 | Int J Endocrinol | Latent Inflammation and Insulin Resistance in Adipose Tissue. | 2017 | Details |